Kinetics of the P-glycoprotein, the multidrug transporter

Experimental Physiology

Volumn 83, Issue 2, 1998, Pages 221-232

  Stein, Wilfred D ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CYTOTOXIN; DAUNORUBICIN; DOXORUBICIN; GLYCINE; GLYCOPROTEIN P; VINBLASTINE;

CELL METABOLISM; CONFERENCE PAPER; DIFFUSION; DRUG UPTAKE; ERYTHROCYTE MEMBRANE; GENE EXPRESSION; MEMBRANE TRANSPORT; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PARTITION COEFFICIENT;

EID: 0031893374     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.1998.sp004106     Document Type: Conference Paper

References (54)

1. AMBUDKAR, S. H., LELONG, I. H., ZHANG, J., CARDARELLI, C. O., GOTTESMAN, M. M. & PASTAN, I. (1992). Partial purification and reconstitution of the human multidrug-resistance pump: Characterization of the drug-stimulatable ATP hydrolysis. Proceedings of the National Academy of Sciences of the USA 89, 8472-8476.
2. BIEDLER, J. L. & RIEHM, H. (1970). Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Reseearch 30, 1174-1184.
3. CHAN, H. S., HADDAD, G., THORNER, P. S., DEBOER, G., LIN, Y. P., ONDRUSEK, N., YEGER, H. & LING, V. (1991). P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. New England Journal of Medicine 325, 1608-1614.
4. COLLANDER, R. (1954). The permeability of Nitella cells to nonelectrolytes. Physiologia Plantarum 7, 420-445.
5. DALMARK, M. & HOFFMAN, E. K. (1983). Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: comparison with transport in human red blood cells. Scandinavian Journal of Clinical Laboratory Investigation 43, 241-248.
6. DALMARK, M. & STORM, H. H. (1981). A Fickian diffusion transport process with features of transport catalysis - doxorubicin transport in human red blood cells. Journal of General Physiology 78, 349-364.
7. DANO, K. (1973). Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochimica et Biophysica Acta 323, 466-483.
8. DEMANT, E. J. F., SEHESTED, M. & JENSEN, P. B. (1990). A model for computer simulation of P-glycoprotein and transmembrane pH-mediated anthracycline transport in multidrug-resistant tumor cells. Biochimica et Biophysica Acta 1055, 117-125.
9. DOIGE, C. A. & AMES, G. F. (1993). ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annual Review of Microbiology 47, 291-319.
10. DORDAL, M. S., WINTER, J. N. & ATKINSON, A. J. J. (1992). Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux. Journal of Pharmacology and Experimental Therapeutics 263, 762-766.
11. ENDICOTT, J. A. & LING, V. (1989). The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry 58, 137-171.
12. FOJO, A., AKIYAMA, S.-I., GOTTESMAN, M. M. & PASTAN, I. (1985). Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Reseearch 45, 3002-3007.
13. GOTTESMAN, M. M. & PASTAN, I. (1988). The multidrug transporter, a double-edged sword. Journal of Biological Chemistry 263, 12163-12166.
14. GROS, P. & BUSCHMAN, E. (1993). The mouse multidrug resistance gene family: structural and functional analysis. International Review of Cytology 137, 169-197.
15. GROS, P., CROOP, J. & HOUSMAN, D. (1986). Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47, 371-380.
16. GROS, P., DHIR, R., CROOP, J. & TALBOT, F. (1991). A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proceedings of the National Academy of Sciences of the USA 88, 7289-7293.
17. HEICHAL, O., ISH-SHALOM, D., KOREN, R. & STEIN, W. D. (1979). The kinetic dissection of transport from metabolic trapping during substrate uptake by intact cells: uridine uptake by quiescent and serum-activated NIL 8 hamster cells and their murine sarcoma virus-transformed counterparts. Biochimica et Biophysica Acta 551, 169-186.
18. HEMPLING, H. G. (1960). Permeability of the Ehrlich ascites cell to water. Journal of General Physiology 44, 365-379.
19. HEMPLING, H. G. (1968). Application of irreversible thermodynamics to a functional description of the tumor cell membrane. Journal of General Physiology 70, 237-256.
20. HORIO, M., LOVELACE, E., PASTAN, I. & GOTTESMAN, M. M. (1991). Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Biochimica et Biophysica Acta 1061, 106-110.
21. INABA, M., KOBAYASHI, H., SAKURAI, Y. & JOHNSON, R. K. (1979). Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Research 39, 2200-2203.
22. JOHNSON, R., CHITNIS, M., EMBREY, W. & GREGORY, E. (1978). In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treatment Reports 62, 1535-1547.
23. KAJIJI, S., TALBOT, F., GRIZZUTI, K., VAN DYKE PHILLIPS, V., AGRESTI, M., SAFA, A. R. & GROS, P. (1993). Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry 32, 4185-4194.
24. KANE, S. E., PASTAN, I. & GOTTESMAN, M. M. (1990). Genetic basis of multidrug resistance of tumor cells. Journal of Bioenergetics and Biomembranes 22, 593-618.
25. LAMPIDIS, T. J., CASTELLO, C., DEL GIGLIO, A., PRESSMAN, B. C., VIALLET, P., TREVORROW, K. W., VALET, G. K., TAPIERO, H. & SAVARAJ, N. (1989). Relevance of the chemical charge of rhodamine dyes to multiple drug resistance. Biochemical Pharmacology 38, 4267-4271.
26. LANKELMA, J., SPOELSTRA, E., DEKKER, H. & BROXTERMAN, H. J. (1990). Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient. Biochimica et Biophysica Acta 1055, 217-222.
27. LEYLAND-JONES, B., DALTON, W., FISHER, G. A. & SIKIC, B. I. (1993). Reversal of multidrug resistance to cancer chemotherapy. Cancer 72, 3484-3488.
28. LIEB, W. R. & STEIN, W. D. (1986). Non-Stokesian nature of transverse diffusion within human red cell membranes. Journal of Membrane Biology 92, 111-119.
29. LITMAN, T. (1991). Multifarmakon Resistens og pH Gradienter. MSc thesis, University of Copenhagen.
30. LUM, B. L. & GOSLAND, M. (1995). MDR expression in normal tissues. Hematology/Oncology Clinics of North America 9, 319-336.
31. LYUBIMOV, E., LAN, L.-B., PASHINSKY, I., AYESH, S. & STEIN, W. D. (1995). Saturation reversal of the multidrug pump using many reversers in low-dose combinations. Anti-Cancer Drugs 6, 727-735.
32. MAYER, L. D., TAI, L. C. L., BALLY, M. B., MITILENES, G. N., GINSBERG, R. S. & CULLIS, P. R. (1990). Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochimica et Biophysica Acta 1025, 143-151.
33. NIELSEN, D., MAARE, C. & SKOVSGAARD, T. (1995). Influx of daunorubicin in multidrug resistant Ehrlich ascites tumor cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil. Biochemical Pharmacology 50, 443-450.
34. PIWNICA-WORMS, D., CHIU, M. L., BUDDING, M., KRONAUGE, J. F., KRAMER, R. A. & CROOP, J. M. (1993). Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Research 53, 977-984.
35. RAVIV, Y., POLLARD, H. B., BRUGGEMANN, E. P., PASTAN, I. & GOTTESMAN, M. M. (1990). Photo-sensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. Journal of Biological Chemistry 265, 3975-3980.
36. SAFA, A. R., STERN, R. K., CHOI, K., AGRESTI, M., TAMAI, I., MEHTA, N. D. & RONINSON, I. B. (1990). Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein. Proceedings of the National Academy of Sciences of the USA 87, 7225-7229.
37. SCHINKEL, A. H., SMIT, J. J., VAN TELLINGEN, O., BEIJNEN, J. H., WAGENAAR, E., VAN DEEMTER, L., MOL, C. A., VAN DER VALK, M. A., ROBANUS MAANDAG, E. C., TE RIELE, H. P., BERNS A. J. M. & BORST, P. (1994). Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
38. SEHESTED, M., SIMPSON, D., SKOVSGAARD, T. & JENSEN, P. B. (1989). Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells. Virchows Archiv B 56, 327-335.
39. SEHESTED, M., SKOVSGAARD, T., VAN DEURS, B. & WINTHER-NIELSEN, H. (1987). Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. Journal of the National Cancer Institute 78, 171-179.
40. SHALINSKY, D. R., JEKUNEN, A. P., ALCARAZ, J. E., CHRISTEN, R. D., KIM, S., KHATIBI, S. & HOWELL, S. B. (1993). Regulation of initial vinblastine influx by P-glycoprotein. British Journal of Cancer 67, 30-36.
41. SHAPIRO, A. B. & LING, V. (1994). ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. Journal of Biological Chemistry 269, 3745-3754.
42. SHAROM, F. J., YU, X., CHU, J. W. K. & DOIGE, C. A. (1995). Characterization of the ATPase activity of P-glycoprotein from multidrug resistant Chinese hamster ovary cells. Biochemical Journal 308, 381-390.
43. SKOVSGAARD, T. (1978a). Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Research 38, 4722-4727.
44. SKOVSGAARD, T. (1978b). Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Research 38, 1785-1791.
45. SMIT, J. J., SCHINKEL, A. H., OUDE ELFERINK, R. P., GROEN, A. K., WAGENAAR, E., VAN DEEMTER, L., MOL, C. A., OTTENHOFF, R., VAN DER LUGT, N. M., VAN ROON, M. A., VAN DER VALK, M. A., OFFERHAUS, G. J. A., BERNS, A. J. M. & BORST, P. (1993). Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462.
46. STEIN, W. D. (1986). Transport and Diffusion Across Cell Membranes. Academic Press, Orlando, FL, USA.
47. STEIN, W. D. (1990). Channels, Carriers, and Pumps: An Introduction to Membrane Transport. Academic Press, San Diego.
48. STEIN, W. D. (1996). Kinetics of the multidrug transporter and its reversal. Physiological Reviews 77, 545-590.
49. STEIN, W. D., CARDARELLI, C., PASTAN, I. & GOTTESMAN, M. M. (1994). Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Molecular Pharmacology 45, 763-772.
50. TANG-WAI, D. F., KAJIJI, S., DICAPUA, F., DE GRAAF, D., RONINSON, I. B. & GROS, P. (1995). Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34, 32-39.
51. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M. M., PASTAN, I. & WILLINGHAM, M. C. (1987). Cellular localization of the multidrug-resistance gene product p-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the USA 84, 7735-7738.
52. TSURUO, T., IIDA, H., YAMASHIRO, M., TSUKAGOSHI, S. & SAKURAI, Y. (1982). Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Biochemical Pharmacology 31, 3138-3140.
53. URBATSCH, I. L., AL-SHAWI, M. K. & SENIOR, A. E. (1994). Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry 33, 7069-7076.
54. WALTER, A. & GUTKNECHT, J. (1986). Permeability of small nonelectrolytes through lipid bilayer membranes. Journal of Membrane Biology 90, 207-217.